Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
she was not successfully immunized (low titers) after 2 prior doses of this vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of therapeutic response decreased in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced therapeutic response decreased (Verbatim: she was not successfully immunized (low titers) after 2 prior doses of this vaccine). The outcome of the therapeutic response decreased was not applicable. Additional Information: GSK Receipt Date : 21-FEB-2025 Pharmacist passed an inquiry from a physician about the possibility of a patient to receive a third dose of Shingrix because she was not successfully immunized (low titers) after 2 prior doses of this vaccine. He mentioned that he did not have any more data of the patient, just mentioned her gender.